NCT01663415View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Metastatic Castration-Resistant Prostate Cancer
Interventions
DRUG

Enzalutamide

oral

Sponsors

Collaborators (1)

Medivation, Inc.
All Listed Sponsors
collaborator

Medivation, Inc.

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY